| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |